OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106,164 | -40.2% | 20,145 | -68.1% | 0.00% | -42.9% |
| Q4 2022 | $177,525 | -64.1% | 63,176 | -47.0% | 0.01% | -58.8% |
| Q3 2022 | $495,000 | +489.3% | 119,265 | +603.8% | 0.02% | +466.7% |
| Q1 2022 | $84,000 | -71.0% | 16,945 | -59.2% | 0.00% | -72.7% |
| Q4 2021 | $290,000 | -19.7% | 41,541 | +15.0% | 0.01% | -15.4% |
| Q3 2021 | $361,000 | -57.5% | 36,107 | -30.2% | 0.01% | -50.0% |
| Q1 2021 | $849,000 | – | 51,726 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |